Special District

Title Sort descending Due Date Maximum Award Amount Description
2023/2024 Monkfish Research Set Aside Varies

NMFS, in coordination with the New England and Mid-Atlantic Fishery Management Councils (Councils), is soliciting proposals under the Monkfish Research Set Aside (RSA) Program. Projects funded under the Monkfish RSA Program must enhance the knowledge of the monkfish fishery resource or contribute to the body of information on which monkfish management decisions are made. Priority will be given to proposals that investigate research priorities developed by the Council, which are detailed under the Program Priorities section of this announcement.Successful applicants will be awarded monkfish RSA days-at-sea (DAS). No federal funds are provided for research under this notification. Rather, proceeds generated from the sale of RSA DAS will be used to fund approved activities.New Program Requirements and Updates:Commercial Fishing Vessel Safety: Fieldwork activities may require additional safety inspections and permitting per US Coast Guard safety requirements. Documentation must be filed with NOAA and approved prior to initiating on-water activities. Complete information concerning this requirement is provided under section IV.B of this announcement.Recipients will be required to submit receipts, or other proof of purchase for any equipment or supplies costing $5,000 or more. The receipts should be included on the next scheduled progress report after the purchase has been made.Section IV – The following parts within this section have been updated: Content and Form of Application; Format; Proposal Content Requirements and Guidelines; and Project Costs and Budget Narrative. Questions on the new requirements should be directed to the Program Officer.Section VI.C – Reporting. Final reports must meet Section 508 Standards. These standardsensure equitable access to final reports. Questions on this requirement should be directed to theProgram Officer.Section V.A.3 The technical score for overall application qualifications has been increased from 10 to 20 points, and now includes consideration of the applicant's knowledge and experience with how funds are derived under an RSA award, and the concept of RSA compensation fishing.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346678
2024 Technical Assistance for Specialty Crops Program $500,000.00

The TASC program is designed to assist U.S. organizations by providing funding for projects that seek to remove, resolve, or mitigate existing or potential sanitary, phytosanitary, or technical barriers that prohibit or threaten the export of U.S. specialty crops. The TASC program is administered by personnel of the Foreign Agricultural Service (FAS) on behalf of the Commodity Credit Corporation (CCC).

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346795
3D Elevation Program (3DEP) Varies

Authority: Public Law 99-591 (43 U.S.C. § 36(c)), the USGS Organic Act of March 3, 1879, as amended (43 U.S.C. § 31 et seq.), 16 U.S.C. § 1(a)(2)(j), 16 U.S.C. § 1(g), 16 U.S.C. § 5933, and 16 U.S.C. § 753(a) Catalog of Federal Domestic Assistance (CFDA) Number 15.808

https://www.grants.gov/web/grants/view-opportunity.html?oppId=344217
A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed) $1,000,000.00

The purpose of this Funding Opportunity Announcement (FOA) is to support multi-disciplinary, multi-component applications proposing the use of omics technologies to advance preventative and/or therapeutic vaccinations, and/or immunomodulatory cure interventions for HIV. Projects will integrate omics, computational, and hypothesis-driven experimental approaches to interrogate immune responses to HIV vaccination and/or cure strategies.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=340775
Academic Development of a Training Program for Good Laboratory Practices in High Containment Environments (U24) Clinical Trials Not Allowed $400,000.00

FDA seeks to continue a robust, collaborative, and educational program using problem-based learning techniques designed to bring researchers and regulators together to educate each other on the challenges related to these issues and to identify solutions that are acceptable from both scientific and regulatory perspectives. This program consists of the continued development and implementation of a certified, academic training course for instruction in Good Laboratory Practices (GLP) in a Biosafety Level (BSL) 4 High Containment Environment.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=334156
Accelerating Data and Metadata Standards in the Environmental Health Sciences (R24 Clinical Trial Not Allowed) $400,000.00

The purpose of this Funding Opportunity Announcement (FOA) is to support resource projects to enable Environmental Health Sciences (EHS) communities to openly develop, extend, adapt, or refine data and metadata standards as well as associated tools to implement standards. The initiative is intended to catalyze community-driven standards development and related implementation in environmental health. Projects can support activities at any point in the data standards lifecycle and should build on existing resources, infrastructure, and partnerships whenever possible. The standards, software, best practices, or other tools developed should be broadly disseminated for adoption by the relevant biomedical communities.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=345352
Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) $275,000.00

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=345845
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) $500,000.00

The purpose of this initiative is to support intervention research that addresses structural racism and discrimination (SRD) to improve minority health or reduce health disparities.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=345671
Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required) $750,000.00

The purpose of this RFA is to support the development and testing of primary care practice- and health system-level interventions and strategies to promote high quality care for adult cancer survivors during and/or after cancer treatment.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346726
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Varies

This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. This FOA solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to accelerate and/or enhance research in cancer biology, early detection and screening, clinical diagnosis, treatment, epidemiology, or address issues associated with cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=344759